Ciplenza
-
Latest News
Favipiravir a broad spectrum inhibitor of viral RNA polymerase emerges as one of most promising drugs for COVID19
CSIR identifies top 25 drugs/drug candidates for repurposing CSIR-IICT, based in Hyderabad, develops a convenient and cost effective synthetic process…
Read More »
